Found 15 matching trials
Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age NA The current study provides data necessary to evaluate the safety and immuno...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years PHASE1 Phase I clinical trial of 24-valent pneumococcal conjugate vaccine (PCV24) ...
Show More Location
Luzhou District Center for Disease Control and Prevention, Changzhi City
Learn More & Join Trial
Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients N/A Ataxia-telangiectasia (AT) is a rare genetic disorder characterized by gait...
Show More Location
Chaim Sheba Medical Center
Learn More & Join Trial
Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants PHASE2 Primary objectives:
* To assess the safety profile of each SP0202 formulat...
Show More Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Learn More & Join Trial
Safety and Immunogenicity of Catch-up Vaccination Regimens of V114 (V114-024) PHASE3 The purpose of this study is 1) to evaluate the safety and tolerability of ...
Show More Location
Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)
Learn More & Join Trial
Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®) PHASE3 The purpose of this study in healthy toddlers who have not previously been ...
Show More Learn More & Join Trial
Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa PHASE4 The purpose of the study is to determine whether prophylactic antipyretic t...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children PHASE4 To compare the ability of Prevnar® to Pneumo® 23 in reducing and preventing...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers PHASE3 The primary objective of this study is to demonstrate the non-inferiority o...
Show More Location
Alabama Clinical Therapeutics Site Number : 8400036
Treatments Being Tested
Meningococcal Polysaccharide (Serogroups A,C,Y and W) Tetanus Toxoid Conjugate vaccine MenACYW conjugate vaccine Meningococcal (Groups A, C, Y and W 135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine Meningococcal Polysaccharide (serogroups A,C,Y and W-135) Diphtheria Toxoid Conjugate Vaccine Diphtheria and Tetanus Toxoids and Acellular Pertussis, inactivated Poliovirus and Haemophilus b Conjugate Vaccine Diphtheria and Tetanus Toxoids and Acellular Pertussis, Hepatitis B and Inactivated Poliovirus Vaccine Haemophilus b Conjugate Vaccine Pneumococcal 13-valent Conjugate Vaccine Rotavirus Vaccine, Live, Oral, Pentavalent Hepatitis B Vaccine Measles, Mumps, and Rubella Virus Vaccine Live Varicella Virus Vaccine Live Learn More & Join Trial
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting N/A The purpose of this study is to learn about how well the 20-valent pneumoco...
Show More Location
El Centro Regional Medical Center
Learn More & Join Trial